Shigang Ding

1.8k total citations
96 papers, 1.2k citations indexed

About

Shigang Ding is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shigang Ding has authored 96 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Surgery, 31 papers in Pulmonary and Respiratory Medicine and 28 papers in Oncology. Recurrent topics in Shigang Ding's work include Helicobacter pylori-related gastroenterology studies (40 papers), Gastric Cancer Management and Outcomes (25 papers) and Galectins and Cancer Biology (13 papers). Shigang Ding is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (40 papers), Gastric Cancer Management and Outcomes (25 papers) and Galectins and Cancer Biology (13 papers). Shigang Ding collaborates with scholars based in China, United States and United Kingdom. Shigang Ding's co-authors include Yanyan Shi, Liya Zhou, Zhu Jin, Hejun Zhang, Rongli Cui, Sanren Lin, Ting Zhang, Huiling Zheng, Chenggang Li and Shant Kumar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shigang Ding

86 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigang Ding China 21 569 385 364 273 211 96 1.2k
Rita Barros Portugal 18 921 1.6× 445 1.2× 602 1.7× 334 1.2× 166 0.8× 35 1.6k
Ioan Jung Romania 20 326 0.6× 396 1.0× 299 0.8× 517 1.9× 67 0.3× 113 1.3k
Kenneth Haines United States 16 290 0.5× 364 0.9× 383 1.1× 130 0.5× 139 0.7× 38 1.2k
Klaus Prenzel Germany 24 827 1.5× 308 0.8× 788 2.2× 442 1.6× 58 0.3× 48 1.7k
Wen‐Liang Fang Taiwan 23 359 0.6× 664 1.7× 459 1.3× 283 1.0× 77 0.4× 61 1.5k
Yusuke Kimura Japan 16 417 0.7× 608 1.6× 317 0.9× 276 1.0× 261 1.2× 55 1.5k
S Matsuno Japan 22 609 1.1× 480 1.2× 332 0.9× 768 2.8× 183 0.9× 70 1.6k
Zhen Huo China 21 480 0.8× 460 1.2× 469 1.3× 651 2.4× 57 0.3× 105 1.5k
Hong Xie China 18 317 0.6× 501 1.3× 126 0.3× 174 0.6× 56 0.3× 42 1.1k
Valentina Indio Italy 24 284 0.5× 584 1.5× 784 2.2× 326 1.2× 109 0.5× 103 1.8k

Countries citing papers authored by Shigang Ding

Since Specialization
Citations

This map shows the geographic impact of Shigang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigang Ding more than expected).

Fields of papers citing papers by Shigang Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigang Ding. The network helps show where Shigang Ding may publish in the future.

Co-authorship network of co-authors of Shigang Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Shigang Ding. A scholar is included among the top collaborators of Shigang Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigang Ding. Shigang Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Xinyu, Shouli Yuan, Meng Qiao, et al.. (2025). Luteolin improves precancerous conditions of the gastric mucosa by binding STAT3 and inhibiting LCN2 expression. International Journal of Biological Sciences. 21(8). 3397–3415. 2 indexed citations
2.
Shen, Yuting, et al.. (2025). Endoscopic and pathological characteristics of gastrointestinal amyloidosis: a retrospective analysis. BMC Gastroenterology. 25(1). 81–81.
4.
Fu, Weiwei, Xinyu Hao, Jing Zhang, et al.. (2025). Dynamic changes of host immune response during Helicobacter pylori-induced gastric cancer development. Clinical & Experimental Immunology. 219(1).
5.
Zhang, Yuxin, Xun Liu, Fang Gu, & Shigang Ding. (2024). Planned Hybrid Endoscopic Submucosal Dissection as Alternative for Colorectal Neoplasms: A Propensity Score-Matched Study. Digestive Diseases and Sciences. 69(3). 949–960. 1 indexed citations
6.
Wang, Ye, et al.. (2024). Helicobacter pylori with trx1 high expression promotes gastric diseases via upregulating the IL23A/NF‐κB/IL8 pathway. Helicobacter. 29(2). e13072–e13072. 2 indexed citations
7.
Fu, Weiwei, et al.. (2024). Prognostic Value of N1/N2 Neutrophils Heterogeneity and Tertiary Lymphoid Structure in Hepatocellular Carcinoma Patients. Cancer Medicine. 13(24). e70551–e70551. 2 indexed citations
8.
Zheng, Huiling, et al.. (2024). Helicobacter pylori infection and inflammasomes. Helicobacter. 29(1). 4 indexed citations
9.
Sun, Qinghua, Ning Jing, Jing Zhang, et al.. (2024). CMTM4 inhibits gastric tumorigenesis and metastasis. Journal of Gastrointestinal Oncology. 15(4). 1431–1445. 1 indexed citations
10.
Gong, Yueqing, Yaxin Lou, Keyan Chen, et al.. (2024). Serum proteomic profiling of precancerous gastric lesions and early gastric cancer reveals signatures associated with systemic inflammatory response and metaplastic differentiation. Frontiers in Molecular Biosciences. 11. 1252058–1252058. 2 indexed citations
11.
Qiao, Meng, Yang Zhao, Miao Xu, et al.. (2024). Increased circulating regulatory T cells and decreased follicular T helper cells are associated with colorectal carcinogenesis. Frontiers in Immunology. 15. 1287632–1287632. 1 indexed citations
13.
Hao, Xinyu, Wei Fu, Yueqing Gong, et al.. (2022). Glucagon-like peptide-2 protects the gastric mucosa via regulating blood flow and metabolites. Frontiers in Endocrinology. 13. 3 indexed citations
14.
Sun, Qinghua, et al.. (2022). Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers. World Journal of Gastroenterology. 28(3). 365–380. 28 indexed citations
15.
Shi, Yanyan, et al.. (2019). Helicobacter pylori -Induced DNA Damage Is a Potential Driver for Human Gastric Cancer AGS Cells. DNA and Cell Biology. 38(3). 272–280. 22 indexed citations
16.
Xue, Hui, Ting Li, Pingzhang Wang, et al.. (2019). CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer. Acta Biochimica et Biophysica Sinica. 51(9). 915–924. 22 indexed citations
17.
Shi, Yanyan, et al.. (2019). <p>Malic enzyme 1 (ME1) is a potential oncogene in gastric cancer cells and is associated with poor survival of gastric cancer patients</p>. OncoTargets and Therapy. Volume 12. 5589–5599. 10 indexed citations
18.
Shi, Yanyan, Ting Zhang, Man Zhou, et al.. (2018). Cellular stress and redox activity proteins are involved in gastric carcinogenesis associated with Helicobacter pylori infection expressing high levels of thioredoxin-1. Journal of Zhejiang University SCIENCE B. 19(10). 750–763. 5 indexed citations
19.
Shi, Yanyan, et al.. (2016). Deoxycholic Acid Could Induce Apoptosis and Trigger Gastric Carcinogenesis on Gastric Epithelial Cells by Quantitative Proteomic Analysis. Gastroenterology Research and Practice. 2016. 1–10. 17 indexed citations
20.
Ding, Shigang. (2005). Eight-year follow-up study on prevalence of gastric cancer and the histopathological changes of gastric mucosa after H.pylori eradication. Zhonghua xiaohua zazhi. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026